“Method Development And Validation Of Ubrogepant In Bulk And Pharmaceutical Dosage Form By Using Rp-Hplc” (2022) Journal of Pharmaceutical Negative Results, pp. 7690–7696. doi:10.47750/pnr.2022.13.S07.929.